KR102682646B1 - 완하용 정제 - Google Patents

완하용 정제 Download PDF

Info

Publication number
KR102682646B1
KR102682646B1 KR1020217014201A KR20217014201A KR102682646B1 KR 102682646 B1 KR102682646 B1 KR 102682646B1 KR 1020217014201 A KR1020217014201 A KR 1020217014201A KR 20217014201 A KR20217014201 A KR 20217014201A KR 102682646 B1 KR102682646 B1 KR 102682646B1
Authority
KR
South Korea
Prior art keywords
tablet
magnesium oxide
volume
granules
laser diffraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217014201A
Other languages
English (en)
Korean (ko)
Other versions
KR20210076066A (ko
Inventor
아츠시 핫토리
Original Assignee
세토라스 홀딩스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세토라스 홀딩스 가부시키가이샤 filed Critical 세토라스 홀딩스 가부시키가이샤
Publication of KR20210076066A publication Critical patent/KR20210076066A/ko
Application granted granted Critical
Publication of KR102682646B1 publication Critical patent/KR102682646B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020217014201A 2018-11-16 2019-11-15 완하용 정제 Active KR102682646B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018215180 2018-11-16
JPJP-P-2018-215180 2018-11-16
PCT/JP2019/044876 WO2020101016A1 (ja) 2018-11-16 2019-11-15 緩下用錠剤

Publications (2)

Publication Number Publication Date
KR20210076066A KR20210076066A (ko) 2021-06-23
KR102682646B1 true KR102682646B1 (ko) 2024-07-09

Family

ID=70731929

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217014201A Active KR102682646B1 (ko) 2018-11-16 2019-11-15 완하용 정제

Country Status (7)

Country Link
US (1) US12053549B2 (cg-RX-API-DMAC7.html)
EP (1) EP3881897B1 (cg-RX-API-DMAC7.html)
JP (3) JP7111389B2 (cg-RX-API-DMAC7.html)
KR (1) KR102682646B1 (cg-RX-API-DMAC7.html)
CN (1) CN113015555B (cg-RX-API-DMAC7.html)
TW (1) TWI724629B (cg-RX-API-DMAC7.html)
WO (1) WO2020101016A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021457908B9 (en) * 2021-07-30 2026-02-05 Setolas Holdings, Inc. Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation
JP7340572B2 (ja) * 2021-08-20 2023-09-07 セトラスホールディングス株式会社 酸化マグネシウム錠剤
CN115487160A (zh) * 2022-09-27 2022-12-20 威海百合生物技术股份有限公司 一种氧化镁片及其制备方法
CN120036483B (zh) * 2025-01-06 2026-03-27 仙乐健康科技股份有限公司 一种微胶囊、片剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8710965D0 (en) 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
KR100972773B1 (ko) * 2001-08-27 2010-07-30 교와 가가꾸고교 가부시키가이샤 제산 ·완하용 정제
JP4015485B2 (ja) 2001-08-27 2007-11-28 協和化学工業株式会社 制酸・緩下用錠剤
JP2006022060A (ja) 2004-07-09 2006-01-26 Kyowa Chem Ind Co Ltd 制酸・緩下用水分散液およびそのための錠剤
DK1973529T3 (da) 2006-01-05 2011-09-12 Veloxis Pharmaceuticals As Fyldbar tablet, som er i stand til at falde hen
WO2008140772A2 (en) * 2007-05-08 2008-11-20 Hercules Incorporated Robust rapid disintegration tablet formulation
MX2009012210A (es) 2007-05-11 2010-01-26 Aloebiotics Res Labs Inc Preparacion de aloe para el mejoramiento de la piel.
JP2010265208A (ja) 2009-05-14 2010-11-25 Kyowa Chem Ind Co Ltd 膵臓機能強化乃至活性化用複合酸化マグネシウム粒子
US20120156293A1 (en) * 2009-09-08 2012-06-21 Hideaki Kitajima Antacid and laxative tablet
JP2014224080A (ja) * 2013-05-17 2014-12-04 協和化学工業株式会社 大腸の検査または手術のための処置剤

Also Published As

Publication number Publication date
KR20210076066A (ko) 2021-06-23
TWI724629B (zh) 2021-04-11
JP2022105754A (ja) 2022-07-14
EP3881897A4 (en) 2022-08-10
JP2023165999A (ja) 2023-11-17
CN113015555A (zh) 2021-06-22
US12053549B2 (en) 2024-08-06
EP3881897B1 (en) 2026-02-18
CN113015555B (zh) 2023-05-30
JP7360503B2 (ja) 2023-10-12
JPWO2020101016A1 (ja) 2021-09-02
EP3881897A1 (en) 2021-09-22
TW202031249A (zh) 2020-09-01
JP7657275B2 (ja) 2025-04-04
JP7111389B2 (ja) 2022-08-02
US20210401754A1 (en) 2021-12-30
WO2020101016A1 (ja) 2020-05-22

Similar Documents

Publication Publication Date Title
JP7657275B2 (ja) 緩下用錠剤
KR101506043B1 (ko) 저치환도 히드록시프로필셀룰로오스를 함유하는 의약 조성물
WO2003103629A1 (en) Orally disintegrating tablets and process for obtaining them.
EP3113770A1 (en) Orally disintegrating tablet of nabilone comprising mannitol-based granules
KR100350565B1 (ko) 세파클로르의약제학적제제
AU2012288632B2 (en) New (trimethoxyphenylamino)pyrimidinyl formulations
US8741344B1 (en) Dispersible tablet
JP5204976B2 (ja) イグラチモドを含有する速崩壊性錠剤
JP2008150364A (ja) レボフロキサシン含有錠剤
Amrutkar et al. Design and evaluation of taste masked chewable dispersible tablet of lamotrigine by melt granulation
AU2013347264B2 (en) Dispersible tablet
AU2025275199B2 (en) Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation
JP2006022060A (ja) 制酸・緩下用水分散液およびそのための錠剤
KR102090784B1 (ko) 빠른 용출률을 나타내는 아토목세틴을 포함하는 경구용 약학 제제 및 이의 제조방법
Mahal et al. Formulation and in-vitro evaluation of orodispersible tablet
Dalai et al. Research Article Formulation and Evaluation of Fexofenadine HCl Fast Dissolving Tablets
US20150283083A1 (en) Dispersible Tablet
Arora et al. Formulation and Evaluation of Fast Dissolving Tablets of Cefixime Trihydrate
JPH05310570A (ja) 粒状製剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20210511

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230913

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20240625

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20240703

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20240704

End annual number: 3

Start annual number: 1

PG1601 Publication of registration